United Therapeutics Corporation

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: United Therapeutics Corporation
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Delaware
Headquarters city: Silver Spring
Headquarters state / province: Maryland
Headquarters country: United States
Fiscal year end: December
Ticker symbol: UTHR
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001082554
EIN: 52-1984749

Board of directors

Follow this board

Christopher Causey · Director
Since 2023
Christopher Patusky · Director
Since 2023
Jan Malcolm · Director
Since 2024
Judy D. Olian · Director
Since 2023
Katherine J. Klein · Director
Since 2023
Kevin Tracey · Director
Since 2026
Linda Maxwell · Director
Since 2023
Louis W. Sullivan · Director
Since 2023
Martine A. Rothblatt · Director · Chairperson & CEO
Since 2023
Nilda Mesa · Director
Since 2023
Ray Kurzweil · Director
Since 2023
Raymond Dwek · Director
Since 2023
Richard Giltner · Director
Since 2023
Tommy G. Thompson · Director
Since 2023
Victor J. Dzau · Director
Since 2026

Chief executives

Martine A. Rothblatt · CHAIRPERSON & CEO

Dates unknown

Director election results

Annual meeting of June 26, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

5 of this board's directors also sit on 8 other boards. 4 are in the same sector.

Shared director Other board Same sector

Ares Management Corporation
via Judy D. Olian
Beta Technologies Inc.
via Martine A. Rothblatt
Emergent BioSolutions Inc. Same sector
via Louis W. Sullivan
Healthpeak Properties Inc.
via Tommy G. Thompson
ImmunityBio Inc. Same sector
via Linda Maxwell
Mattel Inc.
via Judy D. Olian
Scilex Holding Company Same sector
via Tommy G. Thompson
TherapeuticsMD Inc. Same sector
via Tommy G. Thompson

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $863,940; 1 purchase by 1 insider
Sold, last 12 months: $1,429,411,668; 2848 sales by 12 insiders

Date	Insider	Transaction	Shares	Price	Value
Nov 9, 2026	Christopher Patusky Director	Option exercise	+1,210	$132.30	$160,083
Nov 9, 2026	Martine A. Rothblatt Director, Officer (Chairperson & CEO)	Option exercise	+9,500	$117.76	$1,118,720
Nov 9, 2026	Martine A. Rothblatt Director, Officer (Chairperson & CEO)	Open-market sale	−494	$583.80	$288,398
Nov 9, 2026	Christopher Patusky Director	Open-market sale	−1,210	$580.00	$701,800
Nov 9, 2026	Martine A. Rothblatt Director, Officer (Chairperson & CEO)	Open-market sale	−80	$556.52	$44,522
Nov 9, 2026	Martine A. Rothblatt Director, Officer (Chairperson & CEO)	Open-market sale	−840	$584.70	$491,148
Nov 9, 2026	Martine A. Rothblatt Director, Officer (Chairperson & CEO)	Open-market sale	−161	$558.07	$89,849
Nov 9, 2026	Martine A. Rothblatt Director, Officer (Chairperson & CEO)	Open-market sale	−280	$585.63	$163,975
Nov 9, 2026	Martine A. Rothblatt Director, Officer (Chairperson & CEO)	Open-market sale	−168	$558.70	$93,862
Nov 9, 2026	Martine A. Rothblatt Director, Officer (Chairperson & CEO)	Open-market sale	−71	$559.80	$39,746
Nov 9, 2026	Martine A. Rothblatt Director, Officer (Chairperson & CEO)	Open-market sale	−517	$561.15	$290,114
Nov 9, 2026	Martine A. Rothblatt Director, Officer (Chairperson & CEO)	Open-market sale	−512	$562.35	$287,923
Nov 9, 2026	Martine A. Rothblatt Director, Officer (Chairperson & CEO)	Open-market sale	−291	$563.49	$163,976
Nov 9, 2026	Martine A. Rothblatt Director, Officer (Chairperson & CEO)	Open-market sale	−160	$564.36	$90,298
Nov 9, 2026	Martine A. Rothblatt Director, Officer (Chairperson & CEO)	Open-market sale	−220	$565.56	$124,423

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about United Therapeutics Corporation

Who is the CEO of United Therapeutics Corporation?

Martine A. Rothblatt is United Therapeutics Corporation's CHAIRPERSON & CEO.

How many directors are on United Therapeutics Corporation's board?

United Therapeutics Corporation's board has 15 directors: Christopher Causey, Christopher Patusky, Jan Malcolm, Judy D. Olian, Katherine J. Klein, Kevin Tracey, Linda Maxwell, Louis W. Sullivan, Martine A. Rothblatt, Nilda Mesa and 5 others.

Are United Therapeutics Corporation insiders buying or selling shares?

Over the last 12 months, United Therapeutics Corporation insiders bought $863,940 of shares in 1 purchase and sold $1.4 billion of shares in 2848 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is United Therapeutics Corporation connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="united-therapeutics-corporation"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.